The animation presents fine visual detail of the eye anatomy, including the sinuous path of the episcleral veins and the cross-sectional view of the retina that so closely resembles human anatomy, you would think you were examining someone’s actual eye. With this dynamic and detailed animation, healthcare providers, consumers, and investors can better understand how eye pressure is regulated and how Qlaris Bio is attempting to innovate in the field and address an unmet need in treating increased pressure inside the eye.
Staging and Grading Periodontitis
By
admin
The American Academy of Periodontology (AAP) collaborated with XVIVO to showcase their new evidence-based classification system for periodontitis.
THE SCIENCE OF OMEGA-3 HEALTH
By
admin
Prevention Pharma partnered with XVIVO to communicate the science behind their product, OMAX3 The Ultra-Pure Omega-3 Supplement.
LIFE CYCLE OF INFLUENZA A – Narrated by: Forest Whitaker
By
admin
This science animation was developed for Zirus, a biopharmaceutical company that was working on the development of a new class of antivirals. This video excerpt, taken from a larger program developed for Zirus, uses the H1N1 influenza-A virus to example the mechanism of action a virus takes to infect a host cell.
A FOCUS ON ALK-POSITIVE NON-SMALL CELL LUNG CANCER
By
Jordan Maire
In partnership with Wedgewood Communications, XVIVO developed two videos for Takeda Oncology to discuss lung cancer mechanism of disease and treatments.
THORACIC OUTLET SYNDROME
By
Jordan Maire
Dr. Parth Shah, the Director of Vascular and Endovascular Surgery at the Thoracic Outlet Center at Hartford Healthcare’s Heart and Vascular institute asked XVIVO to create an animation of a surgery he performs to relieve a condition called thoracic outlet syndrome, or TOS.
VOXELOTOR AN INVESTIGATIONAL DRUG FOR SICKLE CELL DISEASE
By
admin
In collaboration with Global Blood Therapeutics, our folks here at XVIVO created this medical animation to illustrate the mechanism of action of a potential drug candidate for the treatment of sickle cell disease (SCD).
IDIOPATHIC PULMONARY FIBROSIS AND THE EFFECTS OF TREATMENT
By
admin
The animation, developed in partnership with Wedgewood Communications, shows the mechanism of disease for IPF and the mechanism of action for the recently-approved agent OFEV (nintedanib) from Boehringer Ingelheim.
PALOVAROTENE MOA
By
Jordan Maire
Fibrodysplasia ossificans progressiva, or FOP, is an extremely rare and debilitating disorder, in which bone tissue gradually replaces soft tissue throughout the body, extending the skeleton and “freezing” patients into position.
CUROSURF INTRATRACHEAL SUSPENSION
By
admin
Neonatal respiratory distress syndrome (RDS) is caused by inadequate surfactant production within the underdeveloped lung, …